Curewell Capital Management, LLC

Curewell Capital Management, LLC is an SEC‑registered adviser that provides discretionary investment management exclusively to private pooled investment vehicles (private equity funds) that principally invest in North American healthcare businesses; the firm reported approximately $744.3 million in assets under management and does not advise individual retail clients. Its services for those funds include sourcing and negotiating transactions, portfolio monitoring and the execution of dispositions through the affiliated general partner structures identified in the offering materials.

The firm follows a thematic, research‑driven private equity approach focused on middle‑market healthcare sectors (including services, pharmaceutical services, medical devices and healthcare technology), executing predominantly control investments and working with portfolio company management teams post‑acquisition, often through board representation. Curewell’s operating model explicitly contemplates an authorized Operations Group and a cadre of Special Consultants to provide hands‑on operational, go‑to‑market and integration support, and the firm discloses that it may receive transaction, monitoring and other portfolio‑level compensation in addition to its fund management compensation.

Compared with many institutional managers, Curewell’s Brochure discloses a few practices that are less common among peers: the use of endorsements in its advertising, the systematic deployment of an Operations Group and outside Special Consultants whose compensation and equity arrangements may be paid by portfolio companies, and the firm’s retention of certain transaction and portfolio‑level fees and securities‑based compensation. The Brochure also highlights contractual flexibility—including side‑letter arrangements and placement‑agent relationships—that can result in differing economic or reporting terms for some investors.